Company: OCEA
Filing Date: 2025-04-08
Form Type: 10-K
Source: 0001641172-25-003155
Chunk: 3979

Company: Ocean Biomedical, Inc.
Filing Date: 2025-04-08
Form: 10-K
Item: Item 16
Chunk 3979
---
  
    $105,292  
    $(196,055) 
    $(90,763)

    Net loss 
     -  
     -  
     -  
     (9,480) 
     (9,480)
  
    Stock based compensation 
     -  
     -  
     745  
     -  
     745 
  
    Issuance of common stock 
     169,582  
     -  
     1,795  
     -  
     1,795 
  
    Shares issued to vendors 
     50,000  
     -  
     87  
     -  
     87 
  
    Balances at December 31, 2024 
     35,468,628  
    $-  
    $107,919  
    $(205,535) 
    $(97,616)

    Balances 
     35,468,628  
    $-  
    $107,919  
    $(205,535) 
    $(97,616)

See
accompanying notes to the consolidated financial statements

F-6

OCEAN
BIOMEDICAL, INC. AND SUBSIDIARIES

CONSOLIDATED
STATEMENTS OF CASH FLOWS

(in
thousands)

    2024  
    2023 

    Fiscal Years ended December 31, 

    2024  
    2023 
  
    CASH FLOWS FROM OPERATING ACTIVITIES 

    Net loss 
    $(9,480) 
    $(114,466)
  
    Adjustments to reconcile net loss to net cash used in operating activities: 

    Non-cash interest expense 
     -  
     762 
  
    Non-cash debt issuance costs 
     279  
     627 
  
    Non-cash stock issuances 
     -  
     667 
  
    Stock-based compensation 
     745  
     1,205 
  
    Loss on issuance of warrants 
     -  
     2,301 
  
    Loss on extinguishment of debt 
     -  
     15,080 
  
    Loss on exchange of notes 
     85  
     - 
  
    Loss in connection with Share Consideration